Misoprostol for the prevention and treatment of postpartum hemorrhage

Expert Opinion on Investigational Drugs

Volumn 21, Issue 2, 2012, Pages 235-250

  Sheldon, Wendy R ^a   Blum, Jennifer ^a   Durocher, Jill ^a   Winikoff, Beverly ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

Author keywords

Misoprostol; Postpartum hemorrhage; Prevention; Treatment

Indexed keywords

15 METHYLPROSTAGLANDIN F2ALPHA; ERGOMETRINE; ERGOMETRINE PLUS OXYTOCIN; METHYLERGOMETRINE; METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIN; PLACEBO; UNCLASSIFIED DRUG; UTEROTONIC AGENT;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; POSTPARTUM HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; SHIVERING; TREATMENT INDICATION; TREATMENT OUTCOME;

HUMANS; MISOPROSTOL; OXYTOCICS; POSTPARTUM HEMORRHAGE;

EID: 84855818623     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2012.647405     Document Type: Article

References (77)

1. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74
2. United Nations. The Millennium Development Goals Report 2009 [Online]. 2009. Available from: http://www.un.org/millenniumgoals/pdf/MDG %20Report%202009%20ENG.pdf [Last accessed 26 July 2009]
3. Akins S. Postpartum hemorrhage: a 90s approach to an age-old problem. J Nurse Midwifery 1994;39:123S-34S
4. Cohen WR. Postpartum uterine hemorrhage. In: Cherry SH, Merkatz IR, editors. Complications of pregnancy: medical, surgical, gynecologic, psychosocial and perinatal. 4th edittion. Williams & Wilkins; Baltimore: 1991. p. 1132-41
5. Maine D. Safe motherhood programs: options and issues. Volume 42 Columbia University; New York: 1993
6. Gülmezoglu AM, Villar J, Ngoc NT, et al. WHO multicentre randomised study of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-95 (Pubitemid 32823396)
7. Gülmezoglu AM, Forna F, Villar J, Hofmeyr G. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2007;3:CD000494
8. Alfirevic Z, Blum J, Walraven G, et al. Prevention of postpartum haemorrhage with misoprostol. Int J Gyneacol Obstet 2007;99(Suppl 2):198-201
9. Mousa H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2007;2007(1):1-25
10. Tsu VD, Shane B. New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop. Int J Gyneacol Obstet 2004;85(Suppl 1):S83-93 (Pubitemid 38625921)
11. International Confederation of Midwives. International Federation of Gynaecologists and Obstetricians. Joint statement: management of the third stage of labour to prevent postpartum haemorrhage. J Midwifery Womens Health 2004;49:76-7
12. WHO DoMPS. WHO Recommendations for the Prevention of Postpartum Haemorrhage. World Health Organization; Geneva: 2007
13. Royal College of Obstetricians and Gynaecologists. Prevention and Management of Postpartum Haemorrhage. RCOG Green-top Guideline No. 52. Royal College of Obstetricians and Gynaecologists; London: 2009
14. Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev 2001(4):CD001808
15. McDonald SJ, Abbott JM, Higgins SP. Prophylactic ergometrineoxytocin versus oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2004; Issue 1 Art. No.: CD000201. DOI: 10.1002/14651858.CD000201.pub2.
16. Ç alişkan E, Dilbaz B, Meydanli MM, et al. Oral misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynaecol 2003;101:921-8 (Pubitemid 36561255)
17. Ç alişkan E, Meydanli MM, Dilbaz B, et al. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. Am J Obstet Gynecol 2002;187:1038-45 (Pubitemid 35178408)
18. Walraven G, Blum J, Dampha Y, et al. misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: A randomised controlled trial. BJOG 2005;112(9):1277
19. Garg P, Batra S, Gandhi G. Oral misoprostol versus injectable Methylergometrine in management of the third stage of labor. Int J Gynaecol Obstet 2005;91:160-1 (Pubitemid 41456721)
20. Oboro VO, Tabowei TO. A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour. J Obstet Gynaecol 2003;23:13-16 (Pubitemid 36169541)
21. Ng PS, Chan AS, Sin WK, et al. A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labor. Hum Reprod 2001;16:31-5 (Pubitemid 32058575)
22. Amant F, Spitz B, Timmerman D, et al. misoprostol compared with Methylergometrine for the prevention of postpartum hemorrhage: a double-blinded randomized trial. BJOG 1999;106(10):1066-70 (Pubitemid 29457090)
23. Soltan MH, El-Gendi E, Imam HH, Fathi O. Different doses of sublingual misoprostol versus Methylergometrine for the prevention of atonic postpartum haemorrhage. Int J Health Sci 2007;1:229-36
24. Lam H, Tang OS, Lee CP, Ho PC. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor. Acta Obstet Gynaecol Scand 2004;83:647-50 (Pubitemid 38938753)
25. Gupta B, Jain V, Aggarwal N. Rectal misoprostol versus oxytocin in the prevention of postpartum hemorrhage-A pilot study. Int J Gynaecol Obstet 2006;94(Suppl 2):139-40
26. Chandhiok N, Dhillon B, Datey S, et al. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Intl J Gynaecol Obstet 2006;92:170-5 (Pubitemid 43098890)
27. Afolabi EO, Kuti O, Orji EO, Ogunniyi SO. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labor. Singapore Med J 2010;51(3):207-11
28. Baskett TF, Persad VL, Clough HJ, Young DC. misoprostol versus oxytocin for the reduction of postpartum blood loss. Int J Gynaecol Obstet 2007;97:2-5 (Pubitemid 46349046)
29. Ng PS, Lai CY, Sahota DS, Yuen PM. A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor. Gynecol Obstet Invest 2007;63:55-60 (Pubitemid 46034206)
30. Zachariah E, Naidu M, Seshadri L. Oral misoprostol in the third stage of labor. Int J Gynaecol Obstet 2006;92:23-6 (Pubitemid 41773712)
31. Kundodyiwa TW, Majoko F, Rusakaniko S. misoprostol versus oxytocin in the third stage of labor. Int J Gynaecol Obstet 2001;75:235-41 (Pubitemid 33122079)
32. Walley RL, Wilson JB, Crane JMG, et al. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the managemetn of the third stage of labour. BJOG 2000;107:1111-15
33. Vaid A, Dadhwal V, Mittal S, et al. A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor. Arch Gynecol Obstet 2009;280:893-7
34. Verma P, Aggarwal N, Jain V, Suri V. A double-blind randomized controlled trial to compare sublingual misoprostol with Methylergometrine for prevention of postpartum hemorrhage. Int J Gynaecol Obstet 2006;94(Suppl 2):S137-8 (Pubitemid 44854917)
35. Vimala N, Mittal S, Kumar S, et al. Sublingual misoprostol versus Methylergometrine for active management of the third stage of labor. Int J Gynaecol Obstet 2004;87:1-5 (Pubitemid 39349495)
36. Bugalho A, Daniel A, Faundes A, Cunha M. misoprostol for prevention of postpartum hemorrhage. Int J Gynaecol Obstet 2001;73:1-6 (Pubitemid 32385383)
37. Bamigboye AA, Merrell DA, Hofmeyr GJ, Mitchell R. Randomized comparison of rectal misoprostol with syntometrine for management of the third stage of labor. Acta Obstet Gynaecol Scand 1998;77:178-81 (Pubitemid 28075386)
38. Cook CM, Spurrett B, Murray H. A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour. Aust NZ Obstet Gynaecol 1999;39:414-19
39. Gerstenfeld TS, Wing DA. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. Am J Obstet Gynecol 2001;185:878-82 (Pubitemid 32980530)
40. Enakpene CA, Morhason-Bello IO, Enakpene EO, et al. Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor. J Obstet Gynaecol Res 2007;33:810-17 (Pubitemid 350086513)
41. El-Refaey H, Nooh R, O'Brien P, et al. The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. BJOG 2000;107:1104-10
42. Nasr A, Shahin AY, Elsamman AM, et al. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage. Int J Gynaecol Obstet 2009;105:244-7
43. Penaranda WA, Arrieta OB, Yances BR. Manejo activo del alumbramiento con misoprostol sublingual: un estudio clinico controlado en el hospital de maternidad rafael calvo de cartagena. Revista Colombiana de Obstetricay Ginecologia 2002;53:87-91
44. Parsons SM, Walley RL, Crane JMG, et al. Oral misoprostol versus oxytocin in the management of the third stage of labour. J Obstet Gynaecol Can 2006;28:20-6
45. Diab KM, Ramy AR, Yehia MA. The use of rectal misoprostol as active pharmacological management of the third stage of labor. J Obstet Gynaecol Res 1999;25:327-32 (Pubitemid 29500372)
46. Sloan NL, Durocher J, Aldrich T, et al. What measured blood loss tells us about postpartum bleeding: a systematic review. BJOG 2010;117:788-800
47. Miller S, Tudor C, Thorsten V, et al. Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet. J Midwifery Womens Health 2009;54:133-41; e1
48. Nellore V, Mittal S, Dadhwal V. Rectal misoprostol vs. 15-methyl prostaglandin F2alpha for the prevention of postpartum hemorrhage. Int J Gynaecol Obstet 2006;94:45-6 (Pubitemid 43962996)
49. Hofmeyr JG, Gülmezoglu AM. misoprostol for the prevention and treatment of postpartum haemorrhage. Best Practice & Research Clinical Obstetrics & Gynaecology 2008;22:1025-41.
50. Derman RJ, Kodkany BS, Goudar SS, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 2006;368:1248-53 (Pubitemid 44485797)
51. Høj L, Cardoso P, Nielsen BB, et al. Effect of sublingual misoprostol on severe postpartum hemorrhage in a primary health centre in Guinea-Bissau: randomized double blind clinical trial. BMJ 2005;331(7519):723
52. Mobeen N, Durocher J, Zuberi NF, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakiston: a randomised placebo-controlled trial. BJOG 2011;118:353-61
53. Benchimol M, Gondry J, Mention J-E, et al. Place du misoprostol dans la direction de la delivrance. J Gynaecol Obstet Biol Reprod 2001;30:576-83 (Pubitemid 33000929)
54. Hofmeyr GJ, Nikodem C, de Jager M, Drakely A. Side-effects of oral misoprostol in the third stage of labour-a randomised placebo-controlled trial. S Afr Med J 2001;91:41-4
55. Surbek DV, Fehr PM, Hosli I, Holzgreve W. Oral misoprostol for third stage of labor: a randomized placebo-controlled trial. Obstret Gynaecol 1999;94:255-8 (Pubitemid 29352872)
56. Hofmeyr JG, Nikodem VC, de Jager M, Gelbart BR. A randomized placebo controlled study of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998;105:971-5 (Pubitemid 28442322)
57. Ozkaya O, Sezik M, Kaya H, et al. Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage. J Obstet Gynaecol Res 2005;31:389-93 (Pubitemid 41607081)
58. Bamigboye AA, Hofmeyr GJ, Merrell DA. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial. Am J Obstet Gynecol 1998;179:1043-6 (Pubitemid 28489305)
59. Hofmeyr GJ, Fawole B, Mugerwa K, et al. Administration of 400 ug of misoprostol to augment routine active management of the third stage of labor. Int J Gynaecol Obstet 2011;112:98-102
60. Fawole AO, Sotiloye OS, Hunyinbo KI, et al. A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage. Int J Gynaecol Obstet 2011;112:107-11
61. Hofmeyr GJ, Gülmezoglu AM, Novikova N, et al. misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ 2009;87:666-77
62. Chong YS, Chua S, Shen L, Arulkumaran S. Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery. Obstet Gynecol 2004;131:191-8 (Pubitemid 38456775)
63. Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332-6 (Pubitemid 34168436)
64. Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-91
65. Durocher J, Bynum J, León W, et al. High fever following postpartum administration of sublingual misoprostol. BJOG 2010;117:845-52
66. Chong YS, Chua S, Arulkumaran S. Severe hypothermia following oral misoprostol in the immediate postpartum period. Obstet Gynaecol 1997;90:703-4 (Pubitemid 27413317)
67. Lumbiganon P, Villar J, Piaggio G, et al. Side effects of misoprostol during the first 24 hours after administration in the third stage of labour. BJOG 2002;109:1222-6 (Pubitemid 36164748)
68. Patted SS, Goudar SS, Naik VA, et al. Side effects of oral misoprostol for the prevention of post-partum haemorrhage: results of a community-based randomised controlled trial in rural India. J Matern Fetal Neonatal Med 2009;22:24-8
69. Winikoff B, Dabash R, Durocher J, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010;375:210-16
70. Blum J, Winikoff B, Raghavan S, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 2010;375:217-23
71. Lokugamage AU, Sullivan KR, Niculescu I, et al. A randomized study comparing rectally administered misoprostol versus syntometrine combined with an oxytocin infusion for the cessation of primary postpartum hemorrhage. Acta Obstet Gynecol Scand 2001;80:835-9 (Pubitemid 32846387)
72. Widmer M, Blum J, Hofmeyr GJ, et al. misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet 2010;375:1808-13
73. Zuberi N, Durocher J, Sikander R, et al. misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized controlled-trial in Karachi, Pakistan. BMC Pregnancy Childbirth 2008;8:40
74. Walraven G, Dampha Y, Bittaye B, et al. misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomized controlled trial. BJOG 2004;111:1014-17 (Pubitemid 39223055)
75. Hofmeyr GJ, Ferreira S, Nikodem VC, et al. misoprostol for treating postpartum hemorrhage: a randomized controlled trial. BMC Pregnancy Childbirth 2004;4:16
76. World Health Organization. WHO Model List of Essential Medicines 17th edition [online] 2011. Available from: http://whqlibdoc.who.int/hq/2011/a95053- eng.pdf [Last accessed 13 October 2011]
77. Hofmeyr GJ, Walraven G, Gülmezoglu AM, et al. misoprostol to treat postpartum hemorrhage: a systematic review. BJOG 2005;112:547-53 (Pubitemid 40675787)